Therefore, while well-known FAS inhibitors such as C75 have demonstrated efficacy in inhibiting FAS and regulating fatty acid metabolism [9], there remains a need for the further investigation of effective FAS inhibitors to explore potential improvements in managing obesity. This evidence concerns the gene FAS and obesity due to melanocortin 4 receptor deficiency.